Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES

Approved

STANDARD

ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES

Takeda Pharma Sp. Z O.O.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 26, 2021
Approval ID: 0f54b3ee1c719670
Company: Takeda Pharma Sp. Z O.O.
Type: Standard

Approval Details

Approval Id: 0f54b3ee1c719670
Drug Cima Aemps Name: ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES
Register Number: R-6898IP2
Holder Company Name: Takeda Pharma Sp. Z O.O.
Marketing Company Name: Ecofar Productos S.L.
Authorization Date: 2021-03-26
Dosage Form: COMPRIMIDO GASTRORRESISTENTE
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Takeda Pharma Sp. Z O.O.

Active Ingredients

PANTOPRAZOL

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 26, 2021

Approval ID

0f54b3ee1c719670

Type

Standard

Back to CIMA-AEMPS Approvals

ANAGASTRA 40 MG COMPRIMIDOS GASTRORRESISTENTES - CIMA-AEMPS Drug Approval Details